Disposable Bioreactors Based on Wave Agitation Technology - Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes. - BioPharm

ADVERTISEMENT

Disposable Bioreactors Based on Wave Agitation Technology
Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes.


BioPharm International


DIANA MARJANOVIC is a product manager of disposable bioreactors at Sartorius AG, Switzerland. Gerhard Greller is a scientist in process development, biotechnology, at Sartorius AG, Germany.

References

1. L. Stryer L. Biochemistry, 4th ed. New York (NY): W.H. Freeman and Company; 1995.

2. Wurm F. Nature Biotech 2004;22: 13–98.

3. Sandig V. et al. Mammalian cells. In: Gelissen G., editor. Production of recombinant proteins. (Wiley-VCH; 2005)

4. Weber W. et al. Catching the Wave: The BEVS and the Biowave. Novartis Pharma Research, Switzerland.

5. Eibl D. and Eibl R. BioWorld 2005; 3:1–2 (Supplement BioteCHnet)

6. Pierce, Bioprocessing J 2004; 3: 51–56.

7. Ling et al., Biotechnol Prog 2003; 19(1), 158–62

8. Weber W. et al. Cytotechn 2002; 38: 77–85.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here